Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
← Scanner

MRKMerck & Co., Inc.

Healthcare·Drug Manufacturers—General·NYSE·Mkt cap $250.00B
$124.01
$0.53 (+0.43%) today
IEX feed · not consolidated
Last updated Jul 14, 10:09 AM
65/100 Opportunity
23Risk
57Momentum
56Pullback
75Quality
68Valuation
100Trend
Price & History (up to 5 years)
2025-09-112026-09-11
Low 75.82— support · — resistanceHigh 156.44
Technical Indicators
RSI (14)53.3
MACD hist-0.33
ATR (14)3.08
SMA 20122.70
SMA 50117.97
SMA 200107.22
Rel volume0.3x
Boll upper133.43
Boll lower111.97
52w high130.17
52w low74.19
5y high130.17
5y low61.22
Hist. vol28%
Max drawdown-11%
Long-Term UptrendNeutral MomentumWait for ConfirmationEntry: Pullback Watch
Company QualityHigh Quality
Revenue growth+8.0%
Earnings growth+10.0%
Profit margin+16.0%
ROE+20.0%
Debt/Equity0.60
Free cash flow
P/E22.0
Fwd P/E18.0
P/S4.0
P/B4.5
Div yield+1.5%

Merck & Co., Inc. — Drug Manufacturers—General company in the Healthcare sector.

Decision SummaryInternal Rule-Based Analysis
Current Rating
Neutral / Needs Confirmation
Opportunity Score
65/100
Risk Level
Low
Best Action
Add to watchlist and monitor for confirmation

Why: MRK is trading near recent levels (+0.4% today). Overall, the company is fundamentally strong. The long-term trend remains up. Price is holding above key moving averages with constructive structure. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality75
Historical Context58
Valuation68
Trend100
Momentum57
Pullback56
News Sentiment50
Business Move50
Sector Strength55
Risk/Reward45
Entry Timing55
Sell Risk30
Risk23

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent NewsLive headlines

Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.